Timing of hepatocellular carcinoma (HCC) development and predictability of a modified PAGE-B risk score in caucasian chronic hepatitis B (CHB) patients treated with entecavir (ETV) or tenofovir (TDF)

dc.creator	Papatheodoridis, G. V.	en
dc.creator	Dalekos, G. N.	en
dc.creator	Sypsa, V.	en
dc.creator	Yurdaydin, C.	en
dc.creator	Buti, M.	en
dc.creator	Goulis, I.	en
dc.creator	Chi, H.	en
dc.creator	Manolakopoulos, S.	en
dc.creator	Mangia, G.	en
dc.creator	Gatselis, N.	en
dc.creator	Keskin, O.	en
dc.creator	Savvidou, S.	en
dc.creator	Hansen, B. E.	en
dc.creator	Vlachogiannakos, J.	en
dc.creator	Galanis, K.	en
dc.creator	Idilman, R.	en
dc.creator	Colombo, M.	en
dc.creator	Esteban, R.	en
dc.creator	Janssen, H. L.	en
dc.creator	Lampertico, P.	en
dc.date.accessioned	2015-11-23T10:44:27Z
dc.date.available	2015-11-23T10:44:27Z
dc.date.issued	2014
dc.identifier.issn	0270-9139
dc.identifier.uri	http://hdl.handle.net/11615/31946
dc.source.uri	<Go to ISI>://WOS:000344483801167
dc.subject	Gastroenterology & Hepatology	en
dc.title	Timing of hepatocellular carcinoma (HCC) development and predictability of a modified PAGE-B risk score in caucasian chronic hepatitis B (CHB) patients treated with entecavir (ETV) or tenofovir (TDF)	en
dc.type	journalArticle	en

Files in this item

Files	Size	Format	View
There are no files associated with this item.